Dexamethasone plus HT3 receptor antagonists or metoclopramide vs dexamethasone alone for chemotherapy-induced vomiting

Dexamethasone plus HT3 receptor antagonists or metoclopramide vs dexamethasone alone for chemotherapy-induced vomiting is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Dexamethasone plus HT3 receptor antagonists or metoclopramide vs dexamethasone alone for chemotherapy-induced vomiting ID - 451089 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451089/all/Dexamethasone_plus_HT3_receptor_antagonists_or_metoclopramide_vs_dexamethasone_alone_for_chemotherapy_induced_vomiting PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -